Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ledipasvir/Sofosbuvir in Genotype 2 HCV
NCT02738333Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ledipasvir in chronic hepatitis C genotype 2, sponsored by Gilead Sciences. Started Apr 2016; status: completed.
02
Drugs
ledipasvir
03
Conditions
chronic hepatitis C genotype 2
Beyond the preview
Go deeper on NCT02738333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02738333.